PC_086 Digital health intelligence and community mobilization to expand HPV vaccine coverage and cervical cancer screening
R. Annette (1), S. Tércia (2), F. Herla (3), P. Fabiana (1), B. Regina Flavia (1), C. Marcella (4), D.S. Maria Eduarda (5), R. Samila (5)
(1) Grupo Mulheres Do Brasil, Fortaleza, Brésil, (2) Universidade Federal De Minas Gerais, Belo Horizonte, Brésil, (3) Universidade Federal Do Piauí, Fortaleza, Brésil, (4) Harvard Medical School | Mass General Hospital, Estados Unidos Da América, Brésil, (5) Universidade Federal Do Ceará, Fortaleza, Brésil
PC_065 Preliminary results on a Coriolus versicolor-based vaginal gel for cervical healing and HR-HPV clearance post-conization
C. Álvarez (1), S. Jasmal-Ismail (2), M. Bejarano (3)
(1) Hospital Universitario De Jerez De La Frontera – Jerez De La Frontera (Spain), Jerez De La Frontera, Espagne, (2) Hospital Universitario De Ceuta, Ceuta, Espagne, (3) Hospital Universitario De Jerez De La Frontera, Jerez De La Frontera, Espagne
PC_087 Students knowledge, attitudes, and practices regarding HPV vaccination in Cotonou in 2026.
A.C. Worou (1), V. Blanquet (2), F. Gnangnon (3), N.M. Paraiso (4)
(1) Université D’abomey-Calavi Et Université De Limoge – Cotonou (Bénin), Cotonou, Bénin, (2) Laboratoire D’Epidémiologie Des Maladies Chroniques, Université de Limoges- Limoges (France), Limoges, France, (3) Laboratoire D’epidémiologie Des Maladies Chronique Et Neurologique, Université D’abomey-Calavi – Cotonou (Bénin), Cotonou, Bénin, (4) L’institut Régional De Santé Publique, Université D’abomey-Calavi – Cotonou (Bénin), Cotonou, Bénin
PC_066 Test of cure positivity after LLETZ in an era of primary hrHPV screening
Z. Tugcu (1), K. Madani (1), N. Naveendra (1), M. Mcdonald (1), S. Anipindi (1), G. Makosana (1), Y. Gurtovaya (1), S. Chiu (2), D. Marcus (1), H. Staley (1)
(1) Chelsea And Westminster Hospital Nhs Foundation Trust, London, Royaume-Uni, (2) Imperial College London, London, Royaume-Uni
PC_089 Development of a chatbot as a public health strategy to promote health literacy on cervical cancer prevention
B. Belém Luna Sampaio (1), T. Nascimento Moura (2), E. Carla Figueirêdo Vidal (2), H. Maria Furtado Jorge (3), J. Picanço Magalhães (4), A. Fabiane De Andrade Larre (5), A. Reeves De Castro (6), F. Da Mota Almeida Peroni (6), S. Ann Costa Clemens (7), S. De Jesus Silva Bezerra Dos Anjos (7)
(1) Uece, Fortaleza, Brésil, (2) Urca, Crato, Brésil, (3) Ufpi, Teresina, Brésil, (4) Tactium, Fortaleza, Brésil, (5) Instituto Brasileiro De Controle Do Câncer, São Paulo, Brésil, (6) Grupo Mulheres Do Brasil, Fortaleza, Brésil, (7) Johns Hopkins University, Baltimore, États-Unis
PC_067 Burden of CIN2+ in patients with hrHPV and low-grade cervical cytology
N. Naveendra (1), Z. Tugcu (1), K. Madani (1), M. Mcdonald (1), S. Anipindi (1), G. Makosana (1), Y. Gurtovaya (1), S. Chiu (2), D. Marcus (1), H. Staley (1)
(1) Chelsea And Westminster Hospital Nhs Foundation Trust, London, Royaume-Uni, (2) Imperial College London, London, Royaume-Uni
PC_090 Link between Oral lichen planus and rapid cervical HPV infection progression to CIN2+
I. Muryzina, O. Bilodid, V. Lazurenko
Kharkiv National Medical University, Kharkiv, Ukraine
PC_068 Use of HPV-first and self-collection for post-treatment test-of-cure of CIN2/3
A.D. Iacobone (1), J. Andrews (2)
(1) Irccs, Milano, Italie, (2) Bd, Washington, États-Unis
PC_091 HPV epidemiology in Mexican vaccinated and unvaccinated patients undergoing colposcopy consultation: an ambispective study of the last 10 years.
F. Alcorta-Nuñez, I.E. Tovar-Salas, D.D.J. Gauna-Leal, A. Villarreal-Garza, M. Hernandez-Saldaña, D.C. Pérez-Ibave, C.H. Burciaga-Flores, R. Ibarra-Patiño, O. Vidal-Gutiérrez, M.D.L. Garza-Rodríguez
Centro Universitario Contra El Cáncer-Hospital Universitario U.a.n.l., Monterrey, Mexique
PC_069 Peripartum Outcomes of Cervical Intraepithelial Neoplasia Diagnosed During Pregnancy
O. Noriko, W. Haruka, T. Hiromitsu, T. Akihiko, N. Ruri, H. Sosuke, O. Hiroshi, F. Satoe, T. Yoshimichi, T. Tomohito
Ompu, Osaka, Japon
